Altuner, 2020 - Google Patents
POSSIBLE EFFECTS OF PREEKLAMPSY AND EKLAMPSY THAT MAY OCCUR WITH MATERNAL OBESITY ON THE HEALTH OF PREGNANCY: A METAANALYSISAltuner, 2020
View PDF- Document ID
- 6778136901903131161
- Author
- Altuner Y
- Publication year
- Publication venue
- Medical Diagnosis
External Links
Snippet
It has been determined that the prevalence of overweight" obesity" has gradually increased in women in the last 20 years (88). As a result, it has been suggested that it is associated with obesity during pregnancy, gestational diabetes, hypertensive diseases, preeclampsia …
- 230000035935 pregnancy 0 title abstract description 106
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02411—Detecting, measuring or recording pulse rate or heart rate of foetuses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2221—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0444—Foetal cardiography
- A61B5/0448—Electrodes specially adapted therefor, e.g. scalp electrodes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Altuner | POSSIBLE EFFECTS OF PREEKLAMPSY AND EKLAMPSY THAT MAY OCCUR WITH MATERNAL OBESITY ON THE HEALTH OF PREGNANCY: A METAANALYSIS | |
| Higgins et al. | Obesity and pregnancy | |
| RU2761315C1 (en) | Method for preventing complications of perinatal period | |
| Wright et al. | Problems During Labor and Delivery | |
| Farid et al. | Impact of Low Salt Diet in Upswing Amniotic Fluid Volume in Patients Diagnosed with Oligohydramnios and Assigned for Conservative Management | |
| Crean et al. | Healthcare Considerations for the Pregnant and Postpartum Patient | |
| ELBOGHDADY et al. | Role of Misoprostol (PGE1) before elective caesarean section in decreasing transient tachypnea of the newborn (TTN) | |
| Dharma et al. | Atypical postpartum eclampsia in a 14-year-old woman: a rare case report | |
| Baker et al. | Labor and Delivery at Risk | |
| Abdulrhman et al. | Comparison of General Anesthesia and Regional Anesthesia for Caesarean Section | |
| Ambia et al. | Fetal Heart Rate Tracings Associated With Eclamptic Seizures | |
| Mirzarahimi et al. | The Rate of Cesarean Section and Newborn Apgar score In Two Types Of Physiological Delivery and Facilitated Delivery in Mothers with First Pregnancy | |
| dos Santos Joana et al. | Pregnancy in Patients With McArdle’s Disease | |
| Ghosh | Study of Magnitude of Meconium Stained Amniotic Fluid in Term Pregnancy and Perinatal Outcome | |
| Mohamed et al. | Sildenafil Versus Aspirin with Intrauterine Growth Restriction | |
| Elmesiry et al. | The Neuroprotective Effects of Antenatal Magnesium Sulphate in Preterm Infants: A Randomized Controlled Study | |
| Allert | Obesity and pregnancy outcomes | |
| Shcherbyna | Problem of gestoses | |
| Bahari et al. | Case Report: Monitoring of a High-Risk Pregnancy in a Patient with Imminent Preterm Labor and a History of Poor Obstetric Outcomes | |
| Figueiró | Clinical Predictors of Neonatal Morbidity in a Prospective Cohort of Mothers with Gestational Diabetes | |
| Artyomenko et al. | Selected Lectures in Obstetrics: a manual | |
| Lin et al. | Pregnant Diseases | |
| Christopher | Genesis Journal of Gynecology & Obstetrics | |
| Ketcham et al. | PREGNANCY COMPLICATIONS HEMORRHAGIC CONDITIONS OF EARLY PREGNANCY | |
| Bhaskar et al. | 25 Obesity and Pregnancy |